TenderDekho Logo
GEM

Procurement Opportunity: Cyclophosphamide 500 mg Inj,Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna,Tab Dacomitinib 30 in KOLKATA, WEST BENGAL

Bid Publish Date

17-Mar-2025, 1:08 pm

Bid End Date

07-Apr-2025, 2:00 pm

EMD

₹2,221

Location

KOLKATA , WEST BENGAL

Progress

RA
Issue17-Mar-2025, 1:08 pm
Reverse Auction06-May-2025, 2:00 pm
AwardCompleted
Explore all 5 tabs to view complete tender details

Quantity

9589

Bid Type

Two Packet Bid

Categories 3

ANTIMETABOLITES ANTINEOPLASTIC ANTIBIOTICS INOCULATING DEVICES

Indian Army has released a public tender for Cyclophosphamide 500 mg Inj, Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna, Tab Dacomitinib 30 mg Bottle of 30 Tab, Tab Cabozantinib 60 mg, cabozantinib 40 gm, Inj Bevacizumab 300 mg, Inj Brentuximab Vedotin 50 mg, Pemetrexed 500mg powder for injection, Inj Pemetrexed 100 mg, Bleomycin Sulphate oblique Chloride 15mg Inj, Carboplatin 450mg Inj, Inj Denosumab 120 mg, Inj avelumab 200 mg oblique 10ml, Inj Eribulin, vial of 1 mg, Etoposide 100mg, 5 ml Inj, Pegylated Liposomal Doxorubicin 20mg Inj, Inj Irinotecan 100mg, Gemcitabine 1000mg Inj, Gemcitabine 200mg Inj, inj TPGS Docetaxel 120 mg, inj TPGS Docetaxel 80 mg, inj TPGS Docetaxel 20 mg, Erlotinib 150 mg Tab, Lenvatinib 4 mg tab, Lenvatinib 10 mg tab, Non coring Chemoport Needle 20G, Actinomycin D 0 point 5 mg Inj, 5 Fluorouracil 500mg, 10 ml Inj, Gefitinib 250mg Tab, Trabectadin 1mg powder for Inj, Pazopanib 200mg tab, Inj Pegylated Liposomal Irinotecan 4 point 3mg oblique ml, Tab ruCaparib 200 mg, Oxaliplatin 100mg Inj, Inj Fulvestrant 250 mg, Inj Pegylated GCSF 6mg, Oxaliplatin 50mg Inj in KOLKATA, WEST BENGAL. Quantity: 9589. Submission Deadline: 07-04-2025 14: 00: 00. Download documents and apply online.

Documents 5

GeM-Bidding-7504309.pdf

Main Document

BOQ Document

BOQ

BOQ Document

BOQ

Buyer uploaded ATC document

ATC

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Past Similar Tenders (Historical Results)

5 found

FLUNARIZINE 10MG Tab,FLUOXETINE 10 MG CAP,GABAPENTIN 100 MG CAP,GLIPIZIDE 5 MG TAB,One Touch Select

Indian Army

WEST DELHI, DELHI

Posted: 24 November 2025
Closed: 4 December 2025
GEM

Inj Diclofenac 75 mg oblique ml 1 ml Amp,Aceclofenac 100 mg Paracetamol 500 mg tab,Diclofenac sodiu

Indian Army

Posted: 15 November 2024
Closed: 7 December 2024
GEM

AMILORIDE 5 MG Plus FUROSEMIDE 40 MG TAB,ANGISPANTR 2.5MG CAP NITROCONTIN,ASPIRIN 150 MG Plus CLOPI

Indian Army

PATIALA, PUNJAB

Posted: 13 June 2025
Closed: 4 July 2025
GEM

Inj Xylocaine 2PERCENT Plain,Tab Ecospirin 75 mg,Tab DicolofencPLSU Paracetamol,Inj Diclofenac Aqua

N/a

KODERMA, JHARKHAND

Posted: 23 September 2025
Closed: 30 September 2025
GEM

Mefenmic Acid 250mg Tab,Piroxicam Tab 20 mg,Piroxicam Inj 40 mg in 2 ml amp,Prednisolone tab 5 mg,T

Armed Forces Tribunal

BARAMULLA, JAMMU & KASHMIR

Posted: 16 August 2025
Closed: 26 August 2025
GEM

Bill of Quantities (BOQ) 38 Items

Item # Title Description Quantity Unit Consignee Delivery (Days)
1 Cyclophosphamide 500 mg Inj Cyclophosphamide 500 mg Inj 267 amp oblique vial consignee2dglp 30
2 Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna 90 amp oblique vial consignee2dglp 30
3 Tab Dacomitinib 30 mg Bottle of 30 Tab Tab Dacomitinib 30 mg Bottle of 30 Tab 15 bottle consignee2dglp 30
4 Tab Cabozantinib 60 mg Tab Cabozantinib 60 mg 330 nos consignee2dglp 30
5 cabozantinib 40 gm cabozantinib 40 gm 300 nos consignee2dglp 30
6 Inj Bevacizumab 300 mg Inj Bevacizumab 300 mg 90 vial consignee2dglp 30
7 Inj Brentuximab Vedotin 50 mg Inj Brentuximab Vedotin 50 mg 21 vial consignee2dglp 30
8 Pemetrexed 500mg powder for injection Pemetrexed 500mg powder for injection 75 vial consignee2dglp 30
9 Inj Pemetrexed 100 mg Inj Pemetrexed 100 mg 90 vial consignee2dglp 30
10 Bleomycin Sulphate oblique Chloride 15mg Inj Bleomycin Sulphate oblique Chloride 15mg Inj 36 amp oblique vial consignee2dglp 30
11 Carboplatin 450mg Inj Carboplatin 450mg Inj 300 amp oblique vial consignee2dglp 30
12 Inj Denosumab 120 mg Inj Denosumab 120 mg 45 vial consignee2dglp 30
13 Inj avelumab 200 mg oblique 10ml Inj avelumab 200 mg oblique 10ml 24 vial consignee2dglp 30
14 Inj Eribulin, vial of 1 mg Inj Eribulin, vial of 1 mg 15 vial consignee2dglp 30
15 Etoposide 100mg, 5 ml Inj Etoposide 100mg, 5 ml Inj 180 amp oblique vial consignee2dglp 30
16 Pegylated Liposomal Doxorubicin 20mg Inj Pegylated Liposomal Doxorubicin 20mg Inj 45 vial consignee2dglp 30
17 Inj Irinotecan 100mg Inj Irinotecan 100mg 90 vial consignee2dglp 30
18 Gemcitabine 1000mg Inj Gemcitabine 1000mg Inj 100 vial consignee2dglp 30
19 Gemcitabine 200mg Inj Gemcitabine 200mg Inj 300 vial consignee2dglp 30
20 inj TPGS Docetaxel 120 mg inj TPGS Docetaxel 120 mg 30 no consignee2dglp 30
21 inj TPGS Docetaxel 80 mg inj TPGS Docetaxel 80 mg 60 no consignee2dglp 30
22 inj TPGS Docetaxel 20 mg inj TPGS Docetaxel 20 mg 30 no consignee2dglp 30
23 Erlotinib 150 mg Tab Erlotinib 150 mg Tab 750 no consignee2dglp 30
24 Lenvatinib 4 mg tab Lenvatinib 4 mg tab 600 no consignee2dglp 30
25 Lenvatinib 10 mg tab Lenvatinib 10 mg tab 600 no consignee2dglp 30
26 Non coring Chemoport Needle 20G Non coring Chemoport Needle 20G 300 no consignee2dglp 30
27 Actinomycin D 0 point 5 mg Inj Actinomycin D 0 point 5 mg Inj 120 amp oblique vial consignee2dglp 30
28 5 Fluorouracil 500mg, 10 ml Inj 5 Fluorouracil 500mg, 10 ml Inj 900 amp oblique vial consignee2dglp 30
29 Gefitinib 250mg Tab Gefitinib 250mg Tab 600 no consignee2dglp 30
30 Trabectadin 1mg powder for Inj Trabectadin 1mg powder for Inj 15 vial consignee2dglp 30
31 Pazopanib 200mg tab Pazopanib 200mg tab 1,800 no consignee2dglp 30
32 Inj Pegylated Liposomal Irinotecan 4 point 3mg oblique ml Inj Pegylated Liposomal Irinotecan 4 point 3mg oblique ml 90 vial of 10 ml consignee2dglp 30
33 Tab ruCaparib 200 mg Tab ruCaparib 200 mg 300 nos consignee2dglp 30
34 Bleomycin Sulphate oblique Chloride 15mg Inj Bleomycin Sulphate oblique Chloride 15mg Inj 36 amp oblique vial consignee2dglp 30
35 Oxaliplatin 100mg Inj Oxaliplatin 100mg Inj 150 vial consignee2dglp 30
36 Inj Fulvestrant 250 mg Inj Fulvestrant 250 mg 45 no consignee2dglp 30
37 Inj Pegylated GCSF 6mg Inj Pegylated GCSF 6mg 450 pfs obliquepfp oblique vial consignee2dglp 30
38 Oxaliplatin 50mg Inj Oxaliplatin 50mg Inj 300 amp oblique vial consignee2dglp 30

Reverse Auction Schedule

Completed

Start

06-May-2025, 2:00 pm

End

07-May-2025, 2:00 pm

Duration: 24 hours

Reverse Auction Document

✅ RA concluded. Check financial results for final rankings.

Technical Results

S.No Seller Item Date Status
1**********   Under PMA-05-04-2025 17:55:15Evaluated
2**********   Under PMA-05-04-2025 18:54:33Evaluated
3**********   Under PMA-04-04-2025 19:13:09Evaluated
4**********   Under PMA-07-04-2025 08:37:34Evaluated
5**********   Under PMA-04-04-2025 17:57:05Evaluated
6**********   Under PMA-04-04-2025 15:51:52Evaluated
7**********   Under PMA-07-04-2025 12:27:10Evaluated
8**********   Under PMA-05-04-2025 20:00:40Evaluated
9**********   Under PMA-05-04-2025 16:52:06Evaluated
10**********   Under PMA-28-03-2025 16:12:45Evaluated
11**********   Under PMA-05-04-2025 16:04:07Evaluated
12**********   Under PMA-26-03-2025 15:06:48Evaluated
13**********   Under PMA-07-04-2025 13:55:35Evaluated
14**********   Under PMA-07-04-2025 11:00:02Evaluated
15**********   Under PMA-06-04-2025 23:57:19Evaluated
16**********   Under PMA-07-04-2025 11:49:22Evaluated

Frequently Asked Questions

Key insights about WEST BENGAL tender market

What are the eligibility requirements for bidders in this tender?

The eligibility requirements include being a registered entity capable of supplying pharmaceuticals, possessing the necessary licenses and certifications, and demonstrating experience in similar supply contracts. Bidders must also meet any specific technical qualifications outlined in the tender documentation.

What technical specifications must be adhered to?

Bidders are required to follow technical specifications detailed in the provided BOQ. This includes compliance with quality standards for all pharmaceutical products. Suppliers must present evidence of fulfilling these criteria in their proposals to ensure acceptance by the evaluation committee.

What are the payment terms and performance security requirements?

Payment terms will be outlined in the final contract. Bidders should provide a detailed account of their financial stability. Once awarded, a performance security may be required to guarantee fulfillment of the contract, ensuring compliance with the terms set forth in the tender.

How should the documents be submitted and what formats are accepted?

All documents must be submitted electronically as specified in the tender documentation. Common accepted formats typically include PDF, DOCX, or XLSX. Bidders are advised to adhere to the submission guidelines to ensure all documents are processed efficiently.

Are there any benefits for Micro, Small, and Medium Enterprises (MSEs) participating in this tender?

Yes, provisions are included specifically to foster participation from MSEs, offering benefits that may include lower qualification thresholds, bid preference, and encouragement in alignment with government initiatives for small businesses. This promotes inclusivity and broadens competitive opportunities.